TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Noscapine, Cisplatin
Phytochemical Name Noscapine (PubChem CID: 275196 )
Anticancer drug Name Cisplatin (PubChem CID: 5702198 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 610
Pair Name Noscapine, Cisplatin
Disease Info [ICD-11: 2C73] Ovarian cancer Investigative
Biological Phenomena Induction-->Blockade of cell cycle in G2/M phase
Gene Regulation Down-regulation Expression BIRC5 hsa332
Up-regulation Expression CASP3 hsa836
Down-regulation Expression NFKB1 hsa4790
Down-regulation Expression XIAP hsa331
In Vitro Model SK-OV-3/CDDP Ovarian serous cystadenocarcinoma Homo sapiens (Human) CVCL_D622
In Vivo Model SKOV3/DDP cells in the logarithmic growth stage were diluted to 3×10⁷/ml. Single cell suspension (0.2 ml/mouse) was subcutaneously injected into the right scapular region of nude mice.
Result Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways
Combination Pair ID: 955
Pair Name Noscapine, Cisplatin
Disease Info [ICD-11: 2C25] Lung cancer Investigative
Biological Phenomena Induction-->Apoptosis
Gene Regulation Down-regulation Phosphorylation AKT1 hsa207
Up-regulation Expression BAX hsa581
Up-regulation Expression BCL2 hsa596
Down-regulation Expression BIRC5 hsa332
Up-regulation Cleavage CASP3 hsa836
Up-regulation Cleavage CASP8 hsa841
Up-regulation Cleavage CASP9 hsa842
Up-regulation Expression CASP9 hsa842
Down-regulation Expression CCND1 hsa595
Up-regulation Expression CDKN1A hsa1026
Up-regulation Cleavage PARP1 hsa142
Up-regulation Expression TP53 hsa7157
In Vitro Model NCI-H460 Lung large cell carcinoma Homo sapiens (Human) CVCL_0459
A-549 Lung adenocarcinoma Homo sapiens (Human) CVCL_0023
In Vivo Model For a xenograft model, 3×10⁶ H460 cells were injected subcutaneously into right flank area of mice.
Result Our results suggest that Nos enhanced the anticancer activity of Cis in an additive to synergistic manner by activating multiple signaling pathways including apoptosis. These findings suggest potential benefit for use of Nos and Cis combination in treatment of lung cancer.
03. Reference
No. Title Href
1 Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways. Cell Biochem Biophys. 2015 May;72(1):203-13. doi: 10.1007/s12013-014-0438-y. Click
2 Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer. Lung Cancer. 2011 Mar;71(3):271-82. doi: 10.1016/j.lungcan.2010.06.002. Click
It has been 46327 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP